| 000 | 08620nam a22004333i 4500 | ||
|---|---|---|---|
| 001 | EBC6515583 | ||
| 003 | MiAaPQ | ||
| 005 | 20220324112739.0 | ||
| 006 | m o d | | ||
| 007 | cr cnu|||||||| | ||
| 008 | 220324s2021 xx o ||||0 eng d | ||
| 020 |
_a9783030632779 _q(electronic bk.) |
||
| 020 | _z9783030632762 | ||
| 035 | _a(MiAaPQ)EBC6515583 | ||
| 035 | _a(Au-PeEL)EBL6515583 | ||
| 035 | _a(OCoLC)1249471205 | ||
| 040 |
_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ |
||
| 050 | 4 | _aRC648-665.2 | |
| 082 | 0 | _a615.36 | |
| 100 | 1 | _aKahaly, George J. | |
| 245 | 1 | 0 | _a70 Years of Levothyroxine. |
| 264 | 1 |
_aCham : _bSpringer International Publishing AG, _c2021. |
|
| 264 | 4 | _c�2021. | |
| 300 | _a1 online resource (141 pages) | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 505 | 0 | _aIntro -- Preface -- Contents -- About the Editor and Contributors -- Editor -- Contributors -- Therapeutic Use of Levothyroxine: A Historical Perspective -- 1 Introduction -- 2 Early Beginnings: Growing Understanding of the Thyroid -- 2.1 Cretinism, Goitre, and the Recognition of the Importance of the Thyroid Gland -- 2.2 An Endocrine Function for the Thyroid Gland -- 3 Towards the Modern Era in the Management of Hypothyroidism -- 3.1 Introduction of Chemically Synthesised Thyroid Hormones -- 3.2 Monotherapy or Combination Therapy? -- 3.3 Technological Advances: Better Assays of Thyroid Function -- 3.4 Recent Developments in Levothyroxine Therapy -- 4 Where We Stand Today -- 4.1 A Fuller (But Incomplete) Understanding of Thyroid Hormone Homeostasis -- 4.2 Unresolved Issues and Current Research Questions -- 5 Conclusions -- References -- Administration and Pharmacokinetics of Levothyroxine -- 1 Introduction -- 2 Absorption, Distribution, Metabolism, and Elimination of Levothyroxine -- 2.1 Absorption and Distribution -- 2.2 Metabolism and Elimination -- 3 Factors That May Alter Exposure to an Oral Dose of Levothyroxine -- 3.1 Factors That May Reduce Exposure to Levothyroxine -- 3.1.1 Diurnal Variation -- 3.1.2 Malabsorption of, and Suboptimal Adherence to, Levothyroxine -- 3.2 Factors That May Alter the Measured Level of Thyrotropin -- 4 Levothyroxine Tablets in a Changing Regulatory Environment -- 5 Conclusions -- References -- Pharmacodynamic and Therapeutic Actions of Levothyroxine -- 1 Introduction -- 2 Thyroid Hormone Homeostasis -- 2.1 Conversion of T4 to T3 -- 2.2 Regulation of Deiodinases and Individual "Set Points" for Thyroid Function -- 2.3 Thyroid Hormone Receptors (THRs) -- 2.4 Regulation of TSH Release -- 3 Clinical Pharmacodynamics of (Levo)Thyroxine -- 3.1 Which Thyroid Hormones Are Important? -- 3.2 Actions on Skeletal Muscle. | |
| 505 | 8 | _a3.2.1 Mechanisms -- 3.2.2 Clinical Studies of Interest -- 3.3 Effects on Lipid Profiles -- 3.4 Actions in Adipose Tissue -- 3.5 Effects on Glucose Metabolism -- 3.6 Actions on Mood and Affect -- 3.7 Fatigue -- 3.8 Actions on Inflammation and Haemostasis -- 3.9 Effects in the Kidney -- 3.10 Effects on the Heart and in Bone -- 4 Evidence-Based Guidelines for the Management of Hypothyroidism -- 4.1 Current Status of Evidence-Based Guidelines -- 4.2 Levothyroxine Monotherapy, or Levothyroxine Plus Triiodothyronine, for Hypothyroidism -- 4.3 Barriers to Optimal Care of Patients with Hypothyroidism -- 4.3.1 The Impact of the Diagnosis Itself -- 4.3.2 Avoiding over Diagnosis -- 5 Conclusions -- References -- Levothyroxine in Pregnancy -- 1 Introduction -- 2 Changes in Thyroid Function During Pregnancy -- 3 Maternal and Foetal Outcomes in Women with Hypothyroidism -- 3.1 Effects of Hypothyroidism on Fertility and Preterm Delivery -- 3.2 LT4 Treatment and Pregnancy Outcomes: Importance of Thyroid Autoimmunity -- 3.3 LT4 Treatment of Euthyroid Women with Thyroid Autoimmunity -- 3.4 Thyroid Autoimmunity and Pregnancy Outcomes in Women Receiving Assisted Reproduction Technologies (ART) -- 3.5 Effects on Offspring -- 4 Summary of Current Major Guidelines -- 4.1 Guidelines Considered Here -- 4.2 Overt Hypothyroidism During Pregnancy and Postpartum -- 4.3 Subclinical Hypothyroidism During Pregnancy and Postpartum -- 5 Conclusions -- References -- Levothyroxine in Children -- 1 Introduction -- 2 Overview of Hypothyroidism in Children -- 2.1 Congenital Hypothyroidism -- 2.2 Subclinical Hypothyroidism -- 2.2.1 Prevalence and Clinical Course -- 2.2.2 Outcomes in Children with Subclinical Hypothyroidism -- 2.3 Other Causes of Hypothyroidism in Children -- 3 Effects of Levothyroxine in Children with Hypothyroidism -- 3.1 Congenital or Overt Hypothyroidism. | |
| 505 | 8 | _a3.2 Subclinical Hypothyroidism -- 3.3 Biochemically Euthyroid Children -- 4 Conclusions -- References -- Levothyroxine in the Older Patient -- 1 Thyroid Homeostasis in Older Individuals -- 1.1 Thyroid Homeostasis -- 1.2 Thyroid Hormone Levels and Clinical Outcomes -- 2 Therapeutic Use of Levothyroxine in Older Patients with Hypothyroidism -- 2.1 Analyses from Randomised, Placebo-Controlled Trials -- 2.2 Observational Studies of Levothyroxine in Older Patients with Hypothyroidism -- 2.3 Managing Elderly Patients with Hypothyroidism: Implications of the SORTED 1 Trial -- 3 Conclusions -- References -- Levothyroxine and the Heart -- 1 Introduction -- 2 Overview of the Adverse Effects of Thyroid Dysfunction on the Heart -- 3 Effects of Levothyroxine Replacement Therapy on the Cardiovascular System -- 3.1 Effects on ECG Parameters -- 3.2 Effects of l-Thyroxine on Cardiovascular Structure and Function -- 3.3 Effects of LT4 on Major Adverse Cardiovascular Events -- 3.4 Effects of LT4 in Patients with Heart Failure -- 4 Conclusions -- References -- Levothyroxine and Bone -- 1 Overview of the Effects of Thyroid Hormones on the Skeleton -- 2 Bone Health in Patients Receiving Treatment with Levothyroxine -- 2.1 Patients with Congenital Hypothyroidism -- 2.2 Adult Patients with Hypothyroidism -- 2.2.1 Subclinical Hypothyroidism -- 2.2.2 Overt Hypothyroidism -- 2.3 Effects of Thyrotropin-Suppressive Doses of Levothyroxine -- 3 Clinical Perspectives -- References -- Levothyroxine and Cancer -- 1 Introduction -- 1.1 Overview of the Management of Differentiated Thyroid Cancer -- 1.2 Scope of This Chapter -- 2 Application of Thyrotropin-Suppressive Doses of Levothyroxine After Surgery and Radioactive Iodine for Well-Differentiated Thyroid Tumours -- 2.1 Need for Suppression of Thyrotropin in Thyroid Cancer Survivors. | |
| 505 | 8 | _a2.2 Long-Term Consequences of Thyroidectomy and Thyrotropin Suppression -- 2.2.1 Bone -- 2.2.2 The Cardiovascular System -- 2.2.3 Patient-Reported Outcomes -- 3 Thyroid Hormones and Cancer Risk -- 4 Conclusions -- References -- Practical Application of Levothyroxine-Based Therapy -- 1 Introduction -- 2 Safety and Tolerability of Levothyroxine -- 2.1 Avoiding Symptoms of Thyroid Dysfunction -- 2.2 Adverse Reactions to the LT4 Tablet Itself -- 3 How to Prescribe and Take Levothyroxine -- 4 Overview of Guidelines on the Management of Hypothyroidism -- 5 Conclusions -- References. | |
| 588 | _aDescription based on publisher supplied metadata and other sources. | ||
| 590 | _aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2022. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. | ||
| 655 | 4 | _aElectronic books. | |
| 776 | 0 | 8 |
_iPrint version: _aKahaly, George J. _t70 Years of Levothyroxine _dCham : Springer International Publishing AG,c2021 _z9783030632762 |
| 797 | 2 | _aProQuest (Firm) | |
| 856 | 4 | 0 |
_uhttps://www.nbs.de/bibliothek/faq _zWie greife ich auf das E-Book zu? |
| 856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/nbsde/detail.action?docID=6515583 _zClick to View |
| 999 |
_c2561 _d2561 |
||